1. Home
  2. EDAP vs LNSR Comparison

EDAP vs LNSR Comparison

Compare EDAP & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EDAP TMS S.A.

EDAP

EDAP TMS S.A.

N/A

Current Price

$3.72

Market Cap

163.4M

Sector

Health Care

ML Signal

N/A

Logo LENSAR Inc.

LNSR

LENSAR Inc.

N/A

Current Price

$11.69

Market Cap

146.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EDAP
LNSR
Founded
1979
2004
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Medical Electronics
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
163.4M
146.7M
IPO Year
1998
2005

Fundamental Metrics

Financial Performance
Metric
EDAP
LNSR
Price
$3.72
$11.69
Analyst Decision
Buy
Hold
Analyst Count
3
1
Target Price
$8.50
$15.00
AVG Volume (30 Days)
59.0K
34.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$53,494,000.00
Revenue This Year
N/A
$19.55
Revenue Next Year
$7.15
$35.89
P/E Ratio
N/A
N/A
Revenue Growth
N/A
26.87
52 Week Low
$1.21
$9.46
52 Week High
$5.05
$17.31

Technical Indicators

Market Signals
Indicator
EDAP
LNSR
Relative Strength Index (RSI) 46.03 45.67
Support Level $3.64 $11.15
Resistance Level $4.24 $12.80
Average True Range (ATR) 0.38 0.32
MACD -0.06 -0.02
Stochastic Oscillator 43.23 51.11

Price Performance

Historical Comparison
EDAP
LNSR

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

About LNSR LENSAR Inc.

LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.

Share on Social Networks: